Literature DB >> 5743710

Clinical experience with vincristine (NSC-67574) in tumors of the central nervous system and other malignant diseases.

C R Smart, R E Ottoman, D B Rochlin, J Hornes, A R Silva, H Goepfert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5743710

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  7 in total

1.  CNS Anticancer Drug Discovery and Development Conference White Paper.

Authors:  Victor A Levin; Peter J Tonge; James M Gallo; Marc R Birtwistle; Arvin C Dar; Antonio Iavarone; Patrick J Paddison; Timothy P Heffron; William F Elmquist; Jean E Lachowicz; Ted W Johnson; Forest M White; Joohee Sul; Quentin R Smith; Wang Shen; Jann N Sarkaria; Ramakrishna Samala; Patrick Y Wen; Donald A Berry; Russell C Petter
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

Review 2.  The chemotherapy of posterior fossa tumors in childhood.

Authors:  H S Friedman; W J Oakes
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

3.  Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors.

Authors:  G Comella; G Scoppa; M De Marco; G P Ianniello; G Melillo; F Coucourde; D Zarrilli
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

4.  Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors.

Authors:  Michelle De Witt; Alexander Gamble; Derek Hanson; Daniel Markowitz; Caitlin Powell; Saleh Al Dimassi; Mark Atlas; John Boockvar; Rosamaria Ruggieri; Marc Symons
Journal:  Mol Med       Date:  2017-04-05       Impact factor: 6.354

5.  Penetration of intra-arterially administered vincristine in experimental brain tumor.

Authors:  Frances M Boyle; Susan L Eller; Stuart A Grossman
Journal:  Neuro Oncol       Date:  2004-10       Impact factor: 12.300

6.  Extreme drug resistance in primary brain tumors: in vitro analysis of 64 resection specimens.

Authors:  Raymond I Haroun; Richard E Clatterbuck; M Christopher Gibbons; Peter C Burger; Ricardo Parker; John P Fruehauf; Henry Brem
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

7.  An investigation of the mouse as a model for vincristine toxicity.

Authors:  S D Harrison
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.